- News & Analysis
- Home
- Latest News
- Reports
- Podcast
- The CVC Funding Round Database
- The CVC Directory
- University
- Video
- Subscribe
- Newsletters
- Job Postings
- Events
Page 202
Beam Therapeutics shines in $180m IPO
Genomic medicine developer Beam will raise $180m in a upsized initial public offering three years after being spun out of Harvard University.
Feb 6, 2020Daily deal net: February 6, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Feb 6, 2020Unternehmertum and BMW Foundation aim to Respond
TUM’s tech transfer office will begin training 12 impact-focused startups from June 2020 in an accelerator allied to BMW Foundation Herbert Quandt.
Feb 6, 2020Azafaros fares well in $28m series A
Azafaros, a metabolic disorder drug developer leveraging Leiden University and Amsterdam UMC inventions, has secured $28m in series A capital.
Feb 6, 2020UW forms biomedical commercialisation hub
The biomedical commercialisation hub will invest $200,000 in four to six startups each year from University of Washington and other local centres of research.
Feb 6, 2020Daily deal net: February 5, 2020
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Feb 5, 2020UPMC strives to build pharma firm
UPMC will invest some of its recently announced $1bn healthcare commercialisation budget to create a new pharmaceutical development firm.
Feb 5, 2020Romisher to head Stellenbosch University incubator
LaunchLab has entrusted Joshua Romisher with driving its entry into new African markets beyond its existing purview of South Africa.
Feb 5, 2020ALD NanoSolutions forges ahead with $20m
CU Boulder spinout ALD NanoSolutions has merged with its peer Forge Nano, with new merged company securing $20m from a range of corporates.
Feb 5, 2020Monivent nears $2.1m IPO
Chalmers University of Technology-founded baby ventilation monitor developer Monivent will join the Spotlight Stock Market in an IPO where 60% of shares have advance subscriptions in place.
Feb 4, 2020About us
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits our membership, providing privileged access to all our services and resources.
Navigation
test regLogin
Not yet subscribed?
We use cookies to enhance your browsing experience and analyse our traffic. By clicking "Accept All", you consent to our use of cookies. Accept Read MorePrivacy & Cookies PolicyPrivacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.


